Form 4: Qualys Director Sells Shares Under Pre-Arranged Trading Plan

Qualys Director Jeffrey P. Hank sold 657 shares of common stock for $139.07 per share on June 16, 2025, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Jeffrey P. Hank, a Director of Qualys, Inc. (QLYS), reported a transaction involving the company's common stock.
• On June 16, 2025, Mr. Hank disposed of 657 shares of Qualys common stock.
• The shares were sold at a price of $139.07 per share.
• Following this transaction, Mr. Hank beneficially owns 13,888 shares of Qualys common stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Hank on August 16, 2024.

Sentiment

Score: 5

Explanation: The filing reports a pre-planned sale of shares by a director, which is a routine transaction under a Rule 10b5-1 plan and generally considered neutral in sentiment, as it does not necessarily reflect new information about the company's prospects.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on immediate, non-public information, which can mitigate negative perceptions often associated with insider selling.

Negatives

• The transaction represents a reduction in direct insider ownership, as a director sold shares of the company's common stock.

Risks

• While executed under a pre-arranged plan, insider selling, even if routine, can sometimes be misinterpreted by the market as a lack of confidence, potentially leading to minor negative sentiment.

Future Outlook

NA

Industry Context

This Form 4 filing details a routine insider transaction specific to Qualys, Inc. and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: The sale of shares by a director, even under a pre-arranged plan, slightly reduces insider ownership, which some investors may view as a minor negative signal, though the pre-planned nature mitigates concerns about immediate adverse company developments.

Key Dates

Keywords

Qualys, QLYS, Form 4, insider trading, stock sale, director, Jeffrey P. Hank, 10b5-1 plan, beneficial ownership